{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:11:43Z","timestamp":1780571503021,"version":"3.54.1"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004386","name":"Universiti Malaya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.micpath.2025.107953","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T23:14:13Z","timestamp":1754435653000},"page":"107953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Unlocking nature's hidden treasures: Actinomycetota's arsenal of potent antiviral compounds against human viral infections"],"prefix":"10.1016","volume":"208","author":[{"given":"By Lina","family":"Amrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurin Sabrina","family":"Zawari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Zahirah Afrina","family":"Abd Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adzzie Shazleen","family":"Azman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurshamimi","family":"Nor Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9419-5731","authenticated-orcid":false,"given":"Jasmine Elanie","family":"Khairat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2025.107953_bib1","series-title":"Handbook of Water and Wastewater Microbiology","first-page":"777","article-title":"42 - taste and odour problems in potable water","author":"Ortenberg","year":"2003"},{"key":"10.1016\/j.micpath.2025.107953_bib2","first-page":"7","article-title":"A review on endophytic actinomycetes and their applications","volume":"9","author":"Segaran","year":"2017","journal-title":"J. Chem. Pharmaceut. Res."},{"key":"10.1016\/j.micpath.2025.107953_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2023.102385","article-title":"Antibiotics from rare actinomycetes, beyond the genus streptomyces","volume":"76","author":"Parra","year":"2023","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.micpath.2025.107953_bib4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1513\/pats.200907-077AL","article-title":"Bacteria that masquerade as fungi","volume":"7","author":"Sullivan","year":"2010","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.micpath.2025.107953_bib5","volume":"2015","author":"Saini","year":"2015"},{"key":"10.1016\/j.micpath.2025.107953_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41021-021-00173-7","article-title":"Species diversity and molecular analysis of opportunistic mycobacterium, nocardia and rhodococcus isolated from the hospital environment in a developing country, a potential resources for nosocomial infection","volume":"43","author":"Siavashifar","year":"2021","journal-title":"Gene Environ."},{"key":"10.1016\/j.micpath.2025.107953_bib7","first-page":"36","article-title":"Biodiversity of actinomycetes and their secondary metabolites: a comprehensive review","author":"Khan","year":"2022","journal-title":"J. Adv. Biomed. Pharmac. Sci."},{"key":"10.1016\/j.micpath.2025.107953_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12088-016-0627-z","article-title":"Antibacterial, anticancer and neuroprotective activities of rare actinobacteria from mangrove forest soils","volume":"57","author":"Azman","year":"2017","journal-title":"Indian J. Microbiol."},{"key":"10.1016\/j.micpath.2025.107953_bib9","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1099\/jmm.0.001232","article-title":"Streptomyces from traditional medicine: sources of new innovations in antibiotic discovery","volume":"69","author":"Quinn","year":"2020","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2025.107953_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1475-2859-8-61","article-title":"Selectively improving nikkomycin Z production by blocking the imidazolone biosynthetic pathway of nikkomycin X and uracil feeding in streptomyces ansochromogenes","volume":"8","author":"Liao","year":"2009","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.micpath.2025.107953_bib11","series-title":"Comprehensive Medicinal Chemistry II","first-page":"419","article-title":"7.14 - fungi and fungal disease","author":"Dorr","year":"2007"},{"key":"10.1016\/j.micpath.2025.107953_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/264020","article-title":"Actinomycetes: a repertory of green catalysts with a potential revenue resource","volume":"2013","author":"Prakash","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.micpath.2025.107953_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7164\/antibiotics.28.757","article-title":"Revistin found by screening for inhibitors of reverse transcriptase of an oncogenic virus","volume":"28","author":"Numata","year":"1975","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.micpath.2025.107953_bib14","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3072","article-title":"mRNA stability assay using transcription inhibition by actinomycin D in mouse pluripotent stem cells","volume":"8","author":"Ratnadiwakara","year":"2018","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.micpath.2025.107953_bib15","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1021\/bi002859z","article-title":"Crystallographic analysis of a novel complex of actinomycin D bound to the DNA decamer CGATCGATCG","volume":"40","author":"Robinson","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.micpath.2025.107953_bib16","doi-asserted-by":"crossref","DOI":"10.18231\/j.ijmr.2024.002","article-title":"Important antiviral properties of streptomyces species compounds","volume":"11","author":"Kumar","year":"2024","journal-title":"Indian J. Microbiol. Res."},{"key":"10.1016\/j.micpath.2025.107953_bib17","first-page":"82","article-title":"A new antibiotic, phleomycin","volume":"9","author":"Maeda","year":"1956","journal-title":"J. Antibiot. (Tokyo) Ser. A"},{"key":"10.1016\/j.micpath.2025.107953_bib18","series-title":"Pharmacology and Therapeutics","first-page":"1121","article-title":"Chapter 81 - endocarditis","author":"Winston","year":"2009"},{"key":"10.1016\/j.micpath.2025.107953_bib19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0042-6822(70)90187-X","article-title":"The effect of phleomycin on poliovirus RNA replication","volume":"40","author":"Hecht","year":"1970","journal-title":"Virology"},{"key":"10.1016\/j.micpath.2025.107953_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1128\/jvi.8.1.28-34.1971","article-title":"Differential effect of phleomycin on the infectivity of poliovirus and poliovirus-induced ribonucleic acids","volume":"8","author":"Koch","year":"1971","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107953_bib21","series-title":"Studies in Natural Products Chemistry","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1572-5995(00)80051-4","article-title":"Natural products as antiviral agents","author":"El Sayed","year":"2000"},{"key":"10.1016\/j.micpath.2025.107953_bib22","doi-asserted-by":"crossref","first-page":"588","DOI":"10.36348\/sjmps.2020.v06i09.001","article-title":"Rifampicin as potent inhibitor of COVID -19 main protease: in-silico docking approach","volume":"6","author":"Soni","year":"2020","journal-title":"Saudi J. Med. Pharmac. Sci."},{"key":"10.1016\/j.micpath.2025.107953_bib23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.6308762","article-title":"Ivermectin: a potent new antiparasitic agent","volume":"221","author":"Campbell","year":"1983","journal-title":"Science."},{"key":"10.1016\/j.micpath.2025.107953_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-Approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2025.107953_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3906\/sag-2004-126","article-title":"Emerging and reemerging respiratory viral infections up to Covid-19","volume":"50","author":"\u00c7elik","year":"2020","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.micpath.2025.107953_bib26","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/resp.13558","article-title":"Emerging respiratory infections threatening public health in the Asia-Pacific region: a position paper of the Asian Pacific society of respirology","volume":"24","author":"Park","year":"2019","journal-title":"Respirology"},{"key":"10.1016\/j.micpath.2025.107953_bib27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41579-021-00542-7","article-title":"Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract","volume":"19","author":"Flerlage","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2025.107953_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.OH-0010-2012","article-title":"Emergence of influenza viruses and crossing the species barrier","volume":"1","author":"Ko\u00e7er","year":"2013","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.micpath.2025.107953_bib29","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/ani13101646","article-title":"The impact of human activities on zoonotic infection transmissions","volume":"13","author":"Esposito","year":"2023","journal-title":"Animals"},{"key":"10.1016\/j.micpath.2025.107953_bib30","article-title":"Analysis of circulating respiratory syncytial virus A strains in shanghai, China identified a new and increasingly prevalent lineage within the dominant ON1 genotype","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107953_bib31","first-page":"2","article-title":"A narrative review of influenza: a seasonal and pandemic disease","volume":"42","author":"Moghadami","year":"2017","journal-title":"Iran. J. Med. Sci."},{"key":"10.1016\/j.micpath.2025.107953_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40011-011-0009-6","article-title":"Influenza virus: a brief overview","volume":"82","author":"Dangi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. India B Biol. Sci."},{"key":"10.1016\/j.micpath.2025.107953_bib33","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1038\/ncomms2922","article-title":"Aerosol transmission is an important mode of influenza A virus spread","volume":"4","author":"Cowling","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2025.107953_bib34","series-title":"Influenza (Seasonal)","year":"2023"},{"key":"10.1016\/j.micpath.2025.107953_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11010183","article-title":"Influenza treatment: limitations of antiviral therapy and advantages of drug combination therapy","volume":"11","author":"Batool","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2025.107953_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00224-20","article-title":"Understanding the impact of resistance to influenza antivirals","volume":"34","author":"Holmes","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2025.107953_bib37","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001566","article-title":"JMM profile: rifampicin: a broad-spectrum antibiotic","volume":"71","author":"Hardie","year":"2022","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2025.107953_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jmv.1890060210","article-title":"Inhibition of influenza A virus replication by rifampicin and selenocystamine","volume":"6","author":"Hamzehei","year":"1980","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.micpath.2025.107953_bib39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7164\/antibiotics.43.259","article-title":"SF2487, a new polyether antibiotic produced by actinomadura","volume":"43","author":"Hatsu","year":"1990","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.micpath.2025.107953_bib40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.7164\/antibiotics.44.733","article-title":"Fluvirucins A1, A2, B1, B2, B3, B4 and B5, new antibiotics active against influenza A virus. I. Production, isolation, chemical properties and biological activities","volume":"44","author":"Naruse","year":"1991","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.micpath.2025.107953_bib41","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.7164\/antibiotics.53.1420","article-title":"Structures of fattiviracin family, antiviral antibiotics","volume":"53","author":"Habib","year":"2001","journal-title":"J. Antibiot."},{"key":"10.1016\/j.micpath.2025.107953_bib42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1271\/bbb.65.683","article-title":"Antiviral activity of fattiviracin FV-8 against human immunodeficiency virus type 1 (HIV-1)","volume":"65","author":"Habib","year":"2001","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.micpath.2025.107953_bib43","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.7164\/antibiotics.51.1035","article-title":"Fattiviracin A1, a novel antiviral agent produced by Streptomyces microflavus strain no. 2445. II. Biological properties","volume":"51","author":"Yokomizo","year":"1998","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.micpath.2025.107953_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/v14112452","article-title":"Antiviral potential of natural resources against influenza virus infections","volume":"14","author":"Eichberg","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107953_bib45","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.50.4.1470-1479.2006","article-title":"Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection","volume":"50","author":"Malakhov","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.107953_bib46","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3390\/v14112452","article-title":"Antiviral potential of natural resources against influenza virus infections","volume":"14","author":"Eichberg","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107953_bib47","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1086\/522609","article-title":"DAS181, A novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection","volume":"196","author":"Belser","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107953_bib48","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/infdis\/jis622","article-title":"A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection","volume":"206","author":"Moss","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107953_bib49","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1086\/522609","article-title":"DAS181, A novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection","volume":"196","author":"Belser","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107953_bib50","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/infdis\/jiu105","article-title":"An investigational antiviral drug, DAS181, effectively inhibits replication of zoonotic influenza A virus subtype H7N9 and protects mice from lethality","volume":"210","author":"Marjuki","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107953_bib51","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bbmt.2016.02.011","article-title":"DAS181 for treatment of parainfluenza virus infections in hematopoietic stem cell transplant recipients at a single center","volume":"22","author":"Salvatore","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.micpath.2025.107953_bib52","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.5504\/BBEQ.2011.0097","article-title":"Antiviral potential of a proteolytic inhibitor from Streptomyces chromofuscus 34\u20131","volume":"26","author":"Serkedjieva","year":"2012","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"10.1016\/j.micpath.2025.107953_bib53","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/md11041035","article-title":"Diketopiperazine derivatives from the marine-derived actinomycete streptomyces sp. FXJ7.328","volume":"11","author":"Wang","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.micpath.2025.107953_bib54","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1021\/ol4026809","article-title":"Nitrosporeusines A and B, unprecedented thioester-bearing alkaloids from the arctic Streptomyces nitrosporeus","volume":"15","author":"Yang","year":"2013","journal-title":"Org. Lett."},{"key":"10.1016\/j.micpath.2025.107953_bib55","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1016\/j.tet.2017.07.052","article-title":"Phenolic polyketides from the marine alga-derived streptomyces sp. OUCMDZ-3434","volume":"73","author":"Liu","year":"2017","journal-title":"Tetrahedron"},{"key":"10.1016\/j.micpath.2025.107953_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01441-18","article-title":"Salinomycin inhibits influenza virus infection by disrupting endosomal acidification and viral matrix protein 2 function","volume":"92","author":"Jang","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107953_bib57","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12985-019-1254-1","article-title":"Antiviral activities of extremophilic actinomycetes extracts from Kazakhstan's unique ecosystems against influenza viruses and paramyxoviruses","volume":"16","author":"Berezin","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.micpath.2025.107953_bib58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7324\/JAPS.2020.104014","article-title":"Antiviral activity of geldanamycin and its derivatives against influenza virus","volume":"10","author":"Taechowisan","year":"2020","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.micpath.2025.107953_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2020.104600","article-title":"Antiviral properties of extracts of streptomyces sp. SMU 03 isolated from the feces of Elephas maximus","volume":"143","author":"Li","year":"2020","journal-title":"Fitoterapia"},{"key":"10.1016\/j.micpath.2025.107953_bib60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.9734\/jpri\/2021\/v33i22B31400","article-title":"Evaluating the effect of amine-geldanamycin hybrids on antiviral activity against influenza virus","author":"Taechowisan","year":"2021","journal-title":"J. Pharm. Res. Int."},{"key":"10.1016\/j.micpath.2025.107953_bib61","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eng.2021.05.010","article-title":"Multi-omics-guided discovery of omicsynins produced by streptomyces sp. 1647: pseudo-tetrapeptides active against influenza A viruses and coronavirus HCoV-229E","volume":"16","author":"Sun","year":"2022","journal-title":"Engineering"},{"key":"10.1016\/j.micpath.2025.107953_bib62","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1021\/acs.jnatprod.2c00550","article-title":"Dihydromaniwamycin E, a heat-shock metabolite from thermotolerant streptomyces sp. JA74, exhibiting antiviral activity against influenza and SARS-CoV-2 viruses","volume":"85","author":"Saito","year":"2022","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.micpath.2025.107953_bib63","series-title":"Antiviral Activity of Marine Actinomycetes, Saccharopolyspora jiangxiensis IMA1 Against Influenza A\/(H1N1) pdm09","author":"Kiruba","year":"2023"},{"key":"10.1016\/j.micpath.2025.107953_bib64","doi-asserted-by":"crossref","DOI":"10.1080\/16583655.2024.2418429","article-title":"In silico evaluation of the anti-influenza potential of streptomyces bioactive compounds","volume":"18","author":"Amrani","year":"2024","journal-title":"J. Taibah Univ. Sci."},{"key":"10.1016\/j.micpath.2025.107953_bib65","series-title":"CDC A(H5N1) Bird Flu Response Update","author":"CfDCa","year":"2024"},{"key":"10.1016\/j.micpath.2025.107953_bib66","series-title":"Coronaviruses. Encyclopedia of Infection and Immunity","first-page":"241","author":"Schoeman","year":"2022"},{"key":"10.1016\/j.micpath.2025.107953_bib67","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2025.107953_bib68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/B978-0-12-803109-4.00017-9","article-title":"Family coronaviridae","author":"Payne","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107953_bib69","series-title":"Encyclopedia of Virology","first-page":"428","author":"Liu","year":"2021"},{"key":"10.1016\/j.micpath.2025.107953_bib70","doi-asserted-by":"crossref","DOI":"10.1177\/11786361211002481","article-title":"Corona viruses: a review on SARS, MERS and COVID-19","volume":"14","author":"Chathappady House","year":"2021","journal-title":"Microbiol. Insights"},{"key":"10.1016\/j.micpath.2025.107953_bib71","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1038\/s41598-022-06736-0","article-title":"Discovery of actinomycin L, a new member of the actinomycin family of antibiotics","volume":"12","author":"Machushynets","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.107953_bib72","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3181\/00379727-45-11768","article-title":"Bacteriostatic and bactericidal substances produced by a soil actinomyces","volume":"45","author":"Waksman","year":"1940","journal-title":"PSEBM (Proc. Soc. Exp. Biol. Med.)"},{"key":"10.1016\/j.micpath.2025.107953_bib73","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1128\/jvi.29.1.401-404.1979","article-title":"Inhibition of coronavirus 229E replication by actinomycin D","volume":"29","author":"Kennedy","year":"1979","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107953_bib74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/cber.19550880111","article-title":"\u00fcber antibiotica aus actinomyceten","volume":"88","author":"Brockmann","year":"1955","journal-title":"Chem. Ber."},{"key":"10.1016\/j.micpath.2025.107953_bib75","doi-asserted-by":"crossref","first-page":"10012","DOI":"10.1073\/pnas.0403596101","article-title":"Small molecules targeting severe acute respiratory syndrome human coronavirus","volume":"101","author":"Wu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.micpath.2025.107953_bib76","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bj.2020.08.006","article-title":"Valinomycin as a potential antiviral agent against coronaviruses: a review","volume":"43","author":"Zhang","year":"2020","journal-title":"Biomed. J."},{"key":"10.1016\/j.micpath.2025.107953_bib77","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00023-19","article-title":"High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses","volume":"93","author":"Shen","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107953_bib78","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00086-20","article-title":"Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening","volume":"64","author":"Sandler","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.107953_bib79","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/009127002237994","article-title":"Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects","volume":"42","author":"Guzzo","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.micpath.2025.107953_bib80","article-title":"Drug treatments for covid-19: living systematic review and network meta-analysis","volume":"370","author":"Siemieniuk","year":"2020","journal-title":"Bmj"},{"key":"10.1016\/j.micpath.2025.107953_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.729559","article-title":"Efficacy of COVID-19 treatments: a bayesian network meta-analysis of randomized controlled trials","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.micpath.2025.107953_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107248","article-title":"Efficacy and safety of ivermectin for treatment of non-hospitalized COVID-19 patients: a systematic review and meta-analysis of 12 randomized controlled trials with 7,035 participants","volume":"64","author":"Hernandez","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2025.107953_bib83","series-title":"Ivermectin and COVID-19","year":"2024"},{"key":"10.1016\/j.micpath.2025.107953_bib84","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5501\/wjv.v11.i2.90","article-title":"Rifampicin for COVID-19","volume":"11","author":"Panayiotakopoulos","year":"2022","journal-title":"World J. Virol."},{"key":"10.1016\/j.micpath.2025.107953_bib85","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1099\/jmm.0.001203","article-title":"Potential RNA-Dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2","volume":"69","author":"Pokhrel","year":"2020","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2025.107953_bib86","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s43440-021-00228-0","article-title":"Rifampicin and letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study","volume":"73","author":"Pathak","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.micpath.2025.107953_bib87","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.ijbiomac.2020.09.098","article-title":"Prediction of potential inhibitors for RNA-Dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach","volume":"163","author":"Parvez","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2025.107953_bib88","series-title":"Respiratory Syncytial Virus Infection in Children. Statpearls. Treasure Island (FL): Statpearls Publishing Copyright \u00a9 2023","author":"Jain","year":"2023"},{"key":"10.1016\/j.micpath.2025.107953_bib89","first-page":"75","article-title":"Respiratory syncytial virus: diagnosis, treatment and prevention","volume":"14","author":"Eiland","year":"2009","journal-title":"J. Pediatr. Pharmacol. Therapeut."},{"key":"10.1016\/j.micpath.2025.107953_bib90","article-title":"Respiratory syncytial virus: a comprehensive review of transmission, pathophysiology, and manifestation","volume":"15","author":"Kaler","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.micpath.2025.107953_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27072263","article-title":"Protein and Peptide Substances in the Treatment of Respiratory Syncytial Infection: Current State","author":"Shtro","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2025.107953_bib92","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/v5010211","article-title":"Respiratory syncytial virus entry inhibitors targeting the F protein","volume":"5","author":"Sun","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107953_bib93","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/jp.2008.28","article-title":"Prevention of hospitalization due to respiratory syncytial virus: results from the palivizumab outcomes registry","volume":"28","author":"Frogel","year":"2008","journal-title":"J. Perinatol."},{"key":"10.1016\/j.micpath.2025.107953_bib94","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/QCO.0000000000000952","article-title":"The disease burden of respiratory syncytial virus in infants","volume":"36","author":"Munro","year":"2023","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107953_bib95","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/CMR.00010-16","article-title":"Respiratory syncytial virus: infection, detection, and new options for prevention and treatment","volume":"30","author":"Griffiths","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2025.107953_bib96","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1165\/rcmb.2017-0345OC","article-title":"Targeting intracellular ion homeostasis for the control of respiratory syncytial virus","volume":"59","author":"Norris","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.micpath.2025.107953_bib97","doi-asserted-by":"crossref","first-page":"814","DOI":"10.7164\/antibiotics.27.814","article-title":"Salinomycin, a new polyether antibiotic","volume":"27","author":"Miyazaki","year":"1974","journal-title":"J. Antibiot."},{"key":"10.1016\/j.micpath.2025.107953_bib98","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1021\/ja00998a062","article-title":"The structure of monensic acid, a new biologically active compound","volume":"89","author":"Agtarap","year":"1967","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.micpath.2025.107953_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104774","article-title":"Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry","volume":"177","author":"Blockus","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2025.107953_bib100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/toxins14020138","article-title":"Infectious RNA: human immunodeficiency virus (HIV) biology, therapeutic intervention, and the quest for a vaccine","volume":"14","author":"van Heuvel","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.micpath.2025.107953_bib101","series-title":"Encyclopedia of Sustainability Science and Technology","first-page":"4996","article-title":"HIV\/AIDS global epidemichuman immunodeficiency virus (HIV)global epidemichuman immunodeficiency virus (HIV)Global epidemic","author":"Kanki","year":"2012"},{"key":"10.1016\/j.micpath.2025.107953_bib102","first-page":"191","author":"Li","year":"2015","journal-title":"HIV\/AIDS"},{"key":"10.1016\/j.micpath.2025.107953_bib103","first-page":"5","article-title":"HIV virology and pathogenetic mechanisms of infection: a brief overview","volume":"46","author":"Emanuele","year":"2010","journal-title":"Annali dell'Istituto superiore di sanit\u00e0"},{"key":"10.1016\/j.micpath.2025.107953_bib104","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12906-023-03916-x","article-title":"Antiviral and ROS scavenging potential of Carica papaya linn and Psidium guajava leaves extract against HIV-1 infection","volume":"23","author":"Jadaun","year":"2023","journal-title":"BMC Complement Med. Ther."},{"key":"10.1016\/j.micpath.2025.107953_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11101942","article-title":"Elucidation of antiviral and antioxidant potential of C-Phycocyanin against HIV-1 infection through in silico and in vitro approaches","volume":"11","author":"Jadaun","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.micpath.2025.107953_bib106","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbrc.2004.02.036","article-title":"Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120","volume":"316","author":"Chiba","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2025.107953_bib107","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1016\/j.bmcl.2010.09.010","article-title":"Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte","volume":"20","author":"Ding","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.micpath.2025.107953_bib108","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/molecules18010236","article-title":"4862F, a new inhibitor of HIV-1 protease, from the culture of streptomyces I03A-04862","volume":"18","author":"Liu","year":"2012","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.micpath.2025.107953_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064010","article-title":"The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications","volume":"8","author":"F\u00e9rir","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2025.107953_bib110","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1039\/C7RA13241G","article-title":"Ahmpatinin (i)Bu, a new HIV-1 protease inhibitor, from streptomyces sp. CPCC 202950","volume":"8","author":"Chen","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.micpath.2025.107953_bib111","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/infdis\/jit458","article-title":"Seroprevalence of Herpes simplex virus types 1 and 2--United states, 1999-2010","volume":"209","author":"Bradley","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107953_bib112","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/idr13020049","article-title":"Diagnosis of Herpes simplex virus: laboratory and point-of-care techniques","volume":"13","author":"Nath","year":"2021","journal-title":"Infect. Dis. Rep."},{"key":"10.1016\/j.micpath.2025.107953_bib113","series-title":"Bennett's Principles and Practice of Infectious Diseases","article-title":"138 - herpes simplex virus","author":"Schiffer","year":"2015"},{"key":"10.1016\/j.micpath.2025.107953_bib114","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1080\/21505594.2021.1982373","article-title":"Pathogenesis and virulence of Herpes simplex virus","volume":"12","author":"Zhu","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.micpath.2025.107953_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.00139","article-title":"Current antivirals and novel botanical molecules interfering with Herpes simplex virus infection","volume":"11","author":"\u00c1lvarez","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107953_bib116","series-title":"Antiviral Therapy of HSV-1 and-2. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","author":"Kimberlin","year":"2007"},{"key":"10.1016\/j.micpath.2025.107953_bib117","article-title":"An insight into current treatment strategies, their limitations, and ongoing developments in vaccine technologies against Herpes simplex infections","volume":"11","author":"Sharma","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micpath.2025.107953_bib118","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.7164\/antibiotics.45.1370","article-title":"A new antiherpetic agent, AH-135Y, produced by Streptomyces albovinaceus strain no. AH-135","volume":"45","author":"Uyeda","year":"1992","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.micpath.2025.107953_bib119","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3209\/saj.18_62","article-title":"Fattiviracins, antiviral antibiotics produced by an actinomycete","volume":"18","author":"Uyeda","year":"2004","journal-title":"Actinomycetologica"},{"key":"10.1016\/j.micpath.2025.107953_bib120","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.7164\/antibiotics.48.1234","article-title":"A new antiherpetic agent produced by streptomyces sp. strain no. 758","volume":"48","author":"Uyeda","year":"1995","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.micpath.2025.107953_bib121","doi-asserted-by":"crossref","first-page":"828","DOI":"10.7164\/antibiotics.50.828","article-title":"A new antiherpetic agent, AH-1763 IIa, produced by Streptomyces cyaneus strain no. 1763","volume":"50","author":"Uyeda","year":"1997","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.micpath.2025.107953_bib122","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/B:WIBI.0000023824.20673.2f","article-title":"Antimicrobial and antiviral activities of an actinomycete (streptomyces sp.) isolated from a Brazilian tropical forest soil","volume":"20","author":"Sacramento","year":"2004","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2025.107953_bib123","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1248\/bpb.30.795","article-title":"Differential antiviral activity of benzastatin C and its dechlorinated derivative from Streptomyces nitrosporeus","volume":"30","author":"Lee","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.micpath.2025.107953_bib124","first-page":"356","article-title":"In vitro evaluation of actinomycete crude extracts collected from nile Delta (egypt) for antiviral activity","volume":"3","author":"Moghannem","year":"2013","journal-title":"Am. J. PharmTech Res."},{"key":"10.1016\/j.micpath.2025.107953_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127168","article-title":"Ansamycin derivatives from the marine-derived streptomyces sp. SCSGAA 0027 and their cytotoxic and antiviral activities","volume":"30","author":"Nong","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.micpath.2025.107953_bib126","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1080\/14786419.2019.1686368","article-title":"Octyl substituted butenolides from marine-derived streptomyces koyangensis","volume":"35","author":"Huang","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.micpath.2025.107953_bib127","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s43141-021-00203-5","article-title":"Isolation and characterization of marine sponge-associated streptomyces sp. NMF6 strain producing secondary metabolite(s) possessing antimicrobial, antioxidant, anticancer, and antiviral activities","volume":"19","author":"Fahmy","year":"2021","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.micpath.2025.107953_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020947","article-title":"The peptide A-3302-B isolated from a marine bacterium micromonospora sp. inhibits HSV-2 infection by preventing the viral egress from host cells","volume":"23","author":"Sureram","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.107953_bib129","article-title":"Dengue and zika viruses: epidemiological history, potential therapies, and promising vaccines","volume":"5","author":"Silva","year":"2020","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107953_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104749","article-title":"Antiviral activity of the natural alkaloid Anisomycin against dengue and zika viruses","volume":"176","author":"Quintana","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2025.107953_bib131","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/vaccines12050485","article-title":"Vaccination and control methods of west nile virus infection in equids and humans","volume":"12","author":"Cendejas","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.micpath.2025.107953_bib132","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1590\/0074-02760170044","article-title":"Chikungunya virus: clinical aspects and treatment - a review","volume":"112","author":"Cunha","year":"2017","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.micpath.2025.107953_bib133","doi-asserted-by":"crossref","first-page":"10746","DOI":"10.1021\/acs.jmedchem.3c00924","article-title":"Quinazolinone compounds have potent antiviral activity against zika and dengue virus","volume":"66","author":"Ashraf-Uz-Zaman","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micpath.2025.107953_bib134","article-title":"Drug repurposing approach against chikungunya virus: an in vitro and in silico study","volume":"13","author":"Kasabe","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2025.107953_bib135","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02698-16","article-title":"Insights into the biosynthesis of duramycin","volume":"83","author":"Huo","year":"2017","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.micpath.2025.107953_bib136","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.chom.2016.07.002","article-title":"Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission","volume":"20","author":"Tabata","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micpath.2025.107953_bib137","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2017.07.007","article-title":"Structure-based discovery of clinically approved drugs as zika virus NS2B-NS3 protease inhibitors that potently inhibit zika virus infection in vitro and in vivo","volume":"145","author":"Yuan","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2025.107953_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/v11060524","article-title":"Bafilomycin A1 and U18666A efficiently impair ZIKV infection","author":"Sabino","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107953_bib139","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41429-018-0117-0","article-title":"New tetrahydroquinoline and indoline compounds containing a hydroxy cyclopentenone, virantmycin B and C, produced by streptomyces sp. AM-2504","volume":"72","author":"Kimura","year":"2019","journal-title":"J. Antibiot."},{"key":"10.1016\/j.micpath.2025.107953_bib140","first-page":"63","article-title":"Antimycin A: isolation from a new streptomyces and activity against rice plant blast fungi","volume":"9","author":"Nakayama","year":"1956","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.micpath.2025.107953_bib141","article-title":"Identification of potential inhibitors of ZIKV replication","author":"Vasquez","year":"2020","journal-title":"Annual Meet.: AAAS"},{"key":"10.1016\/j.micpath.2025.107953_bib142","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01471-19","article-title":"Labyrinthopeptins exert broad-spectrum antiviral activity through lipid-binding-mediated virolysis","volume":"94","author":"Prochnow","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.107953_bib143","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virol.2021.07.003","article-title":"Labyrinthopeptin A1 inhibits dengue and zika virus infection by interfering with the viral phospholipid membrane","volume":"562","author":"Oeyen","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.micpath.2025.107953_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/v15081773","article-title":"Antiviral activities of streptomyces KSF 103 methanolic extracts against dengue virus Type-2","volume":"15","author":"Zulkifli","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107953_bib145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","article-title":"Monkeypox (mpox) virus: classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis","volume":"16","author":"Karagoz","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.micpath.2025.107953_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12070947","article-title":"Human monkeypox: a comprehensive overview of epidemiology, pathogenesis, diagnosis, treatment, and prevention strategies","volume":"12","author":"Mart\u00ednez-Fern\u00e1ndez","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2025.107953_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106027","article-title":"Monkeypox virus: a review","volume":"176","author":"Letafati","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2025.107953_bib148","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s11357-022-00611-6","article-title":"Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries","volume":"44","author":"Quarleri","year":"2022","journal-title":"Geroscience"},{"key":"10.1016\/j.micpath.2025.107953_bib149","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.virs.2022.07.006","article-title":"Monkeypox virus: a re-emergent threat to humans","volume":"37","author":"Gong","year":"2022","journal-title":"Virol. Sin."},{"key":"10.1016\/j.micpath.2025.107953_bib150","article-title":"Human monkeypox: current state of knowledge and implications for the future","volume":"1","author":"Brown","year":"2016","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107953_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2023.106960","article-title":"Challenges in the treatment and prevention of monkeypox infection; A comprehensive review","volume":"245","author":"Nyame","year":"2023","journal-title":"Acta Trop."},{"key":"10.1016\/j.micpath.2025.107953_bib152","series-title":"WHO Director-General Declares Mpox Outbreak a Public Health Emergency of International Concern - Emergency Committee","year":"2024"},{"key":"10.1016\/j.micpath.2025.107953_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102855","article-title":"The 2022 outbreak and the pathobiology of the monkeypox virus","volume":"131","author":"Kumar","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.micpath.2025.107953_bib154","article-title":"Growing mpox outbreak prompts WHO to declare global health emergency","author":"Kozlov","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2025.107953_bib155","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7319a3","article-title":"US preparedness and response to increasing clade I mpox cases in the democratic republic of the congo\u2014united states, 2024","volume":"73","author":"McQuiston","year":"2024","journal-title":"MMWR Morbidity Mortal. Weekly Rep."},{"key":"10.1016\/j.micpath.2025.107953_bib156","first-page":"1","article-title":"Managing monkeypox virus infections: a contemporary review","volume":"49","author":"Asadi Noghabi","year":"2024","journal-title":"Iran. J. Med. Sci."},{"key":"10.1016\/j.micpath.2025.107953_bib157","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04745-22","article-title":"Identification of in vitro inhibitors of monkeypox replication","volume":"11","author":"Chiem","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.micpath.2025.107953_bib158","series-title":"Viral Polymerases","first-page":"135","article-title":"Chapter 5 - poliovirus polymerase: an effective target for design and development of antipolio drugs","author":"Gupta","year":"2019"},{"key":"10.1016\/j.micpath.2025.107953_bib159","series-title":"A History of Poliomyelitis","author":"Paul","year":"1971"},{"key":"10.1016\/j.micpath.2025.107953_bib160","first-page":"79","article-title":"The poliomyelitis story: a scientific hegira","volume":"58","author":"Horstmann","year":"1985","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.micpath.2025.107953_bib161","series-title":"Polio. our World in Data","author":"Dattani","year":"2022"},{"key":"10.1016\/j.micpath.2025.107953_bib162","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3390\/diagnostics14131436","article-title":"Lymphocytic choriomeningitis virus infections in Hungary between 2017\u20132023\u2014Investigation of the first congenital infections","volume":"14","author":"Koroknai","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.micpath.2025.107953_bib163","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082318","article-title":"Discovery of potent broad spectrum antivirals derived from marine actinobacteria","volume":"8","author":"Raveh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2025.107953_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104558","article-title":"The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors","volume":"169","author":"Kim","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2025.107953_bib165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0163-7258(80)90011-X","article-title":"Antiviral agents from natural sources","volume":"10","author":"Becker","year":"1980","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2025.107953_bib166","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ymeth.2015.07.008","article-title":"Single cell mass cytometry reveals remodeling of human T cell phenotypes by Varicella zoster virus","volume":"90","author":"Sen","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.micpath.2025.107953_bib167","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/1874357901812010080","article-title":"Zoonotic viral diseases of equines and their impact on human and animal health","volume":"12","author":"Kumar","year":"2018","journal-title":"Open Virol. J."},{"key":"10.1016\/j.micpath.2025.107953_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/v13061078","article-title":"Cytomegalovirus infection and inflammation in developing brain","volume":"13","author":"Krstanovi\u0107","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107953_bib169","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1248\/yakushi.124.469","article-title":"[Metabolites produced by actinomycetes--antiviral antibiotics and enzyme inhibitors]","volume":"124","author":"Uyeda","year":"2004","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.micpath.2025.107953_bib170","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1271\/bbb.65.861","article-title":"Biosynthesis of fattiviracin FV-8, an antiviral agent","volume":"65","author":"Habib","year":"2001","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.micpath.2025.107953_bib171","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12985-019-1254-1","article-title":"Antiviral activities of extremophilic actinomycetes extracts from Kazakhstan's unique ecosystems against influenza viruses and paramyxoviruses","volume":"16","author":"Berezin","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.micpath.2025.107953_bib172","article-title":"Identification, bioactivity, and productivity of actinomycins from the marine-derived Streptomyces heliomycini","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107953_bib173","doi-asserted-by":"crossref","first-page":"15633","DOI":"10.1073\/pnas.0907572106","article-title":"Mechanism by which the lectin actinohivin blocks HIV infection of target cells","volume":"106","author":"Tanaka","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2025.107953_bib174","doi-asserted-by":"crossref","DOI":"10.3390\/v15051211","article-title":"Natural products and derivatives as potential zika virus inhibitors: a comprehensive review","volume":"15","author":"Pereira","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107953_bib175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijmm.2013.08.013","article-title":"New aminocoumarin antibiotics as gyrase inhibitors","volume":"304","author":"Heide","year":"2014","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2025.107953_bib176","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1124\/mol.106.028076","article-title":"Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha","volume":"70","author":"Lim","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.micpath.2025.107953_bib177","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejmech.2013.08.053","article-title":"Pyrazole containing natural products: synthetic preview and biological significance","volume":"69","author":"Kumar","year":"2013","journal-title":"Eur. J. Med. Chem."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025006783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025006783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:11:27Z","timestamp":1758582687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025006783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":177,"alternative-id":["S0882401025006783"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107953","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlocking nature's hidden treasures: Actinomycetota's arsenal of potent antiviral compounds against human viral infections","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107953"}}